German company BioNTech should be able to adapt its coronavirus vaccine relatively quickly in response to the emergence of the Omicron variant, BioNTech CEO Ugur Sahin told the Reuters Next conference on Friday.
AMWAJ Real Estate
German company BioNTech should be able to adapt its coronavirus vaccine relatively quickly in response to the emergence of the Omicron variant, BioNTech CEO Ugur Sahin told the Reuters Next conference on Friday.